REVOLUTION MEDICINES INC's ticker is RVMD and the CUSIP is 76155X100. A total of 2 filers reported holding REVOLUTION MEDICINES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $572,727 | +627.0% | 20,691 | +602.6% | 0.02% | +500.0% |
| Q2 2023 | $78,779 | +106358.1% | 2,945 | -13.8% | 0.00% | +50.0% |
| Q1 2023 | $74 | +60.9% | 3,418 | +76.5% | 0.00% | 0.0% |
| Q4 2022 | $46 | -100.0% | 1,937 | -67.5% | 0.00% | 0.0% |
| Q3 2022 | $117,000 | -4.9% | 5,951 | -5.8% | 0.00% | -33.3% |
| Q2 2022 | $123,000 | -35.3% | 6,319 | -15.1% | 0.00% | +50.0% |
| Q1 2022 | $190,000 | +1.1% | 7,439 | -0.6% | 0.00% | -33.3% |
| Q4 2021 | $188,000 | +12.6% | 7,483 | +23.4% | 0.00% | -25.0% |
| Q3 2021 | $167,000 | +24.6% | 6,066 | +43.8% | 0.00% | +33.3% |
| Q2 2021 | $134,000 | +42.6% | 4,219 | +106.5% | 0.00% | +50.0% |
| Q1 2021 | $94,000 | -38.6% | 2,043 | -47.1% | 0.00% | -60.0% |
| Q4 2020 | $153,000 | -57.1% | 3,863 | -62.3% | 0.01% | +25.0% |
| Q3 2020 | $357,000 | +301.1% | 10,247 | +262.5% | 0.00% | 0.0% |
| Q2 2020 | $89,000 | – | 2,827 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Nextech Invest Ltd. | 4,839,529 | $104,824,198 | 43.76% |
| Column Group LLC | 4,577,840 | $99,156,014 | 35.85% |
| Mass General Brigham, Inc | 338,191 | $7,325 | 5.71% |
| Boxer Capital, LLC | 4,684,264 | $101,461 | 4.98% |
| BVF INC/IL | 4,955,588 | $107,338,036 | 3.92% |
| DAFNA Capital Management LLC | 575,785 | $12,471,503 | 3.74% |
| EcoR1 Capital, LLC | 5,352,183 | $115,928,284 | 3.73% |
| Casdin Capital, LLC | 1,810,000 | $39,204,600 | 3.23% |
| Artal Group S.A. | 2,070,988 | $44,858 | 2.66% |
| Integral Health Asset Management, LLC | 345,000 | $7,472,700 | 1.50% |